chr13-32379413-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000059.4(BRCA2):​c.8851G>A​(p.Ala2951Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00692 in 1,613,810 control chromosomes in the GnomAD database, including 134 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A2951G) has been classified as Uncertain significance. The gene BRCA2 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.0084 ( 38 hom., cov: 33)
Exomes 𝑓: 0.0068 ( 96 hom. )

Consequence

BRCA2
NM_000059.4 missense

Scores

6
3
5

Clinical Significance

Benign reviewed by expert panel P:1B:46O:1

Conservation

PhyloP100: 7.91

Publications

77 publications found
Variant links:
Genes affected
BRCA2 (HGNC:1101): (BRCA2 DNA repair associated) Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
BRCA2 Gene-Disease associations (from GenCC):
  • BRCA2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia complementation group D1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005076319).
BP6
Variant 13-32379413-G-A is Benign according to our data. Variant chr13-32379413-G-A is described in ClinVar as Benign. ClinVar VariationId is 41570.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00841 (1281/152290) while in subpopulation AMR AF = 0.0508 (777/15300). AF 95% confidence interval is 0.0478. There are 38 homozygotes in GnomAd4. There are 724 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 38 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000059.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
NM_000059.4
MANE Select
c.8851G>Ap.Ala2951Thr
missense
Exon 22 of 27NP_000050.3A0A7P0T9D7
BRCA2
NM_001432077.1
c.8851G>Ap.Ala2951Thr
missense
Exon 22 of 27NP_001419006.1A0A7P0T9D7
BRCA2
NM_001406720.1
c.8851G>Ap.Ala2951Thr
missense
Exon 22 of 27NP_001393649.1A0A8V8TPZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
ENST00000380152.8
TSL:5 MANE Select
c.8851G>Ap.Ala2951Thr
missense
Exon 22 of 27ENSP00000369497.3P51587
BRCA2
ENST00000544455.6
TSL:1
c.8851G>Ap.Ala2951Thr
missense
Exon 22 of 27ENSP00000439902.1P51587
BRCA2
ENST00000530893.7
TSL:1
c.8482G>Ap.Ala2828Thr
missense
Exon 22 of 27ENSP00000499438.2A0A590UJI7

Frequencies

GnomAD3 genomes
AF:
0.00835
AC:
1270
AN:
152172
Hom.:
34
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0502
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0141
Gnomad FIN
AF:
0.000754
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00512
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00955
AC:
2395
AN:
250796
AF XY:
0.00886
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.0378
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.000786
Gnomad NFE exome
AF:
0.00493
Gnomad OTH exome
AF:
0.00670
GnomAD4 exome
AF:
0.00677
AC:
9893
AN:
1461520
Hom.:
96
Cov.:
31
AF XY:
0.00681
AC XY:
4951
AN XY:
727048
show subpopulations
African (AFR)
AF:
0.00114
AC:
38
AN:
33458
American (AMR)
AF:
0.0392
AC:
1751
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.00138
AC:
36
AN:
26120
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39662
South Asian (SAS)
AF:
0.0146
AC:
1256
AN:
86188
European-Finnish (FIN)
AF:
0.000543
AC:
29
AN:
53412
Middle Eastern (MID)
AF:
0.00486
AC:
28
AN:
5764
European-Non Finnish (NFE)
AF:
0.00574
AC:
6378
AN:
1111850
Other (OTH)
AF:
0.00620
AC:
374
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
490
981
1471
1962
2452
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00841
AC:
1281
AN:
152290
Hom.:
38
Cov.:
33
AF XY:
0.00972
AC XY:
724
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41554
American (AMR)
AF:
0.0508
AC:
777
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.0141
AC:
68
AN:
4828
European-Finnish (FIN)
AF:
0.000754
AC:
8
AN:
10614
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00513
AC:
349
AN:
68008
Other (OTH)
AF:
0.00992
AC:
21
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
66
132
197
263
329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00536
Hom.:
18
Bravo
AF:
0.00992
TwinsUK
AF:
0.00566
AC:
21
ALSPAC
AF:
0.00649
AC:
25
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00570
AC:
49
ExAC
AF:
0.00782
AC:
949
Asia WGS
AF:
0.00693
AC:
24
AN:
3478
EpiCase
AF:
0.00491
EpiControl
AF:
0.00563

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
13
Breast-ovarian cancer, familial, susceptibility to, 2 (13)
-
-
10
not specified (11)
-
-
6
not provided (6)
-
-
5
Hereditary breast ovarian cancer syndrome (5)
-
-
5
Hereditary cancer-predisposing syndrome (5)
-
-
2
Familial cancer of breast (2)
-
-
2
Malignant tumor of breast (2)
-
-
1
BRCA2-related cancer predisposition (1)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Fanconi anemia complementation group D1 (1)
1
-
-
Ovarian cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.060
CADD
Pathogenic
26
DANN
Pathogenic
1.0
Eigen
Pathogenic
0.83
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Pathogenic
0.98
D
MetaRNN
Benign
0.0051
T
MetaSVM
Uncertain
-0.23
T
PhyloP100
7.9
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-1.2
N
REVEL
Uncertain
0.40
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Vest4
0.51
MVP
0.89
MPC
0.16
ClinPred
0.020
T
GERP RS
5.6
gMVP
0.33
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11571769; hg19: chr13-32953550; COSMIC: COSV66463542; COSMIC: COSV66463542; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.